← Every company

Elanco Animal Health Inc Insider Trading

Every director, officer and 10% holder of Elanco Animal Health Inc has to report each trade in its stock within two business days of making it. This is those filings.

ELAN on carbonthat →
Insiders filing
9
32 reported lines
Open-market buys
5
$1.5M
Open-market sales
0
Net
$1.5M
bought more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

InsiderActionValue
Lawrence Erik KurziusDirector2026-08-2040K shat $23.40
Purchase
$935.9K
Shiv O'NeillGC AND CORP SEC2026-08-184K shat $23.58
Purchase
$94.3K
Michael J HarringtonDirector2026-08-125K shat $21.82
Purchase
$109.1K
Robert M VanHimbergenEVP and CFO2026-08-074.2K shat $23.08
Purchase
$96.9K
Paul HerendeenDirector2026-08-0710K shat $23.69
Purchase
$236.9K

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on ELAN

Follow Elanco Animal Health Inc (ELAN) by email

New trades in Elanco Animal Health Inc (ELAN) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets